Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
-HESG- look strong up 20+ and running..Steady Vol..
-HESG- 20+ and moving on up Good vol steady and strong
Up 20+ HESG, Looking strong
"HESG" Kicking strong up 20+ and good steady Vol...
HESG still up 20 persent and High Vol..
They want it to move up, but the sit on the bid, cant have it both ways, support the ask and the bid moves to, this isnt are first dance together.. the girl in the nice dress at the Haytt is more then the girl on the corner..haha and cleaner too..haha
Pizza, that more then interesting, that solid cash money...
porrtorich, I understand, i do it all the time..
MM's dont own everybody...
I think we are 1 or 2 day for that deal to be siged off on, and then one behind the other..
Sorry about that 7x11 and 5x12
LV2 bid= 7x15, ASK= 5x12
I hope the PR show's the deals signed sealed and delivered..one right after the other...he didnt go there for two weeks for nothing...
Dude, this is with out news..and the best is yet to come...
I believe this is due, I like it..
More then tight, flippers arent killing us, becasue the cant buy, but at the same time their holding pretty strong on the ones they do have and not selling them in..I believe news this week will push this over the edge...
Welcome back GoGo Girl, thought we lost ya..
417steve. free 30 day trail.. snagit.com , youll love it.. you can do full screen or bits and peices of one...
Some people get it, some dont...thats why the make the almond joy and the mounds..haha
417steve, what program are you trying to do the snap shot with,,
BiomedReports: News and FDA Updates for Health Sciences Group (OTC:HESG), Hospira (NYSE:HSP), ICON (NASDAQ:ICLR)
Pasadena, CA, Dec 07, 2009 (M2 PRESSWIRE via COMTEX) -- BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.
A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com
On 04/12/09, Health Sciences Group, Inc. (OTC:HESG) would like to announce that it is in strong negotiations to acquire a minority stake in two separate Montana-based marijuana growing, distribution and care giving operations.
On 04/12/09, Hospira, Inc. (NYSE:HSP), a leading global specialty pharmaceutical and medication delivery company, announced the launch of its next-generation 50 mL and 100 mL VisIV(TM) containers for intravenous (I.V.) medications and solutions, and now offers a complete size range (50 mL to 1 L) of the award-winning, environmentally responsible VisIV product.
On 04/12/09, ICON plc, (NASDAQ:ICLR) announced it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.
Biotech investors interested in seeing more details about these stories and accessing the complete database of clinical trials and upcoming FDA decisions can access that information here:
http://biomedreports.com/fda-calendar/fda-calendar.html
Disclosure: No positions.
About BiomedReports.Com
BioMedReports.com is a news portal covering the biomedical news and financial sector. It features its own blog, discussion forum, stock research reports, news feeds, videos, press release capability, stock commentaries, and other unique content - including FDA and Clinical Trial Calendars plus a database that includes about 1,000 stocks and exchange-traded funds from the healthcare sector which are organized into various new healthcare stock indexes.
For more biomedical sector and investment news, go to www.BioMedReports.com
Certain sections of this report contain forward-looking statements that are based on our reporters' expectations, estimates, projections and assumptions. Words such as "expects" "anticipates" "plans" "believes" "scheduled" "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements, which include but are not limited to projections of revenues, earnings, segment performance, cash flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors including but not limited to the status or outcome of legal and/or regulatory proceedings.
All forward-looking statements speak only as of the date of this report or, in the case of any document incorporated by reference, the date of that document. All subsequent written and oral forward-looking statements attributable to the company or any person acting on the company's behalf are qualified by the cautionary statements in this section. BioMedReports.Com does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this report.
CONTACT: M. Davila, Editor, BioMedReports.Com e-mail: support@biomedreports.com Tel: +1 323 472 4480 Fax: +1 888 210 3556
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2009 M2 COMMUNICATIONS
**********************************************************************
As of Thursday, 12-03-2009 23:59, the latest Comtex SmarTrend? Alert, an automated pattern recognition system, indicated an UPTREND on 03-16-2009 for HSP @ $25.10.
For more information on SmarTrend, contact your market data provider or go to www.mysmartrend.com
SmarTrend is a registered trademark of Comtex News Network, Inc. Copyright ? 2004-2009 Comtex News Network, Inc. All rights reserved.
Going to feed my sick body, I will be back in a few..
I think you forgot, the OTCBB company can to them to roll into their shell, the love the business and they have already been to the office and looked at the book, I wouldnt be surprised to have a early Xmas present or a happy new year..That saves them alot of time and money.. I think this is going there..
People at lunch did because they didnt read whats going on and sold out, I love it buy um and up we will go...
I see the flippers came out at lunch, buy it up so there gone and this will run again while their working, that what we where waiting for..
Gibber, I believe that is one of the thing they are working on...I think we are headed with them..
Eric, I was very sick over the weekend, dont even know if I can make it thur the whole day here.. so i could be saying or spelling why off, I love where this is right know, cuz the buyers are only solid people and I dont think they will flip today which is great..As you can see me note are long..so I will shut up..
I am glad you are, I am too, thats why I dont want people to go in utill we do more DD, I like the deal but the numbers have to work out on paper and the story needs to be stronger then this, for us to help them/company, becasuse we have to help each other first..
-Eric-, that wasn't directed at you.. I just hit reply to your post and stead of new, I was saying all the people sitting at the 12 bid should support the ask at 13 and this will go to a new level..
luvn socal, anytime..
05gtoman, this is all good with me, all the people sitting on the Bid should step up to the 13, and move this along..these are strong buys today, look no flippers, you got to love that, and this is with out the news...I almost think that they need that the news paper sticky above was coming out and that scared the MM's, this could have traded almost 2 bill Friday...that hugh..Just a tought..
humbleboss, you right, move you buy up to 13 get filled and the train will move this to the next level for you people..
LV2 running 11x12 and ask 5x13
No problem, we like girls..haha..
Everyone please welcome Candy Girl, she is new and might need a little help...
amirs9, thats because most of the flippers cant buy today, this is the solid buys and shouldnt go down cuz there not flippers on one tick.. this will be solid at what ever price we take it today..
Any time rogus...
imdave, you need to get your eyes checked and come back...013 and moving up..
LV2 Bid=11x12 ASK= 5x13 and alot of buying..
Yep, and he said he doesnt control the MM's, He was happy to see that the MM's arent controling us too..I believe when news comes out this week from the contract from the last news, say bye bye, this is going to rock..